P2-004

N/A

Report date: 2023/05/05 17:36:47

Base Information

Drug NameP2-004
Drug Alias NameP2-004
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, Mantle-CellLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Boan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Boan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, Mantle-CellLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A